Research is only possible with the help of dedicated families! We greatly appreciate your commitment and support.
We’re currently recruiting for the following studies:
Coronavirus and Perinatal Experiences Study
The COPE Study is currently recruiting participants.
The COPE Study is a study that aims to learn more about people’s experiences and feelings during and after the COVID-19 pandemic.
We are currently recruiting pregnant people between 20 and 34 weeks gestation. We are recruiting both substance-using and non-substance-using participants.
Participants will complete two sets of surveys online. The first set of surveys will be completed every 2 weeks for up to 12 weeks during pregnancy to see how feelings and experiences change over time. Participants will complete the second set of surveys at 1 month postpartum, 6 months postpartum and 12 months postpartum. The first set will take about 15-20 minutes, and the second set will take about one to one and a half hours.
We may ask to collect biological samples from participants and their babies. This can be done at OHSU or at home with a collection kit and detailed instructions. These samples may include saliva, hair, nails, blood and breast milk at various time points during pregnancy and postpartum.
We may also ask participants for birth samples which would include placenta samples as well as cord samples collected at delivery.
Lastly, we may ask participants to complete a visit with study staff observing their infant’s behavior at 6 months old. This visit can be done remotely.
This study is in collaboration with NYU and is part of a larger, international COVGEN collaboration, learn more about this here: https://www.covgen.org/
The PENGuIN Study
The PENGuIN Study, part of a NIDA Center of Excellence with the University of Oregon, looks at thinking and mood in individuals from pregnancy through the first year postpartum. We are interested in how thinking patterns and mood may change when individuals are in treatment or recovery for opioid use. We collect information on thinking, feeling, and the brain during and after pregnancy, as well as infant and parent interactions and infant development. This information may help us find ways to better support parents throughout the postpartum period.
To learn more about the PENGuIN Study, visit our FAQ page.
Funded by NIDA (P50DA048756-01).
*Regular text messages are not secured by a technical process called encryption so there may be some level of risk the information could be read by someone besides you.
Roo Study on Mom and Baby Well-Being
The Roo Study examined potential effects of a mindfulness intervention, Mindfulness Based Cognitive Therapy (MBCT), during pregnancy. MBCT connects women with training in skills that promote well-being, reduce mood symptoms, and improve emotional responding during pregnancy and postpartum. We collected data on mental stress and well-being during pregnancy, as well as infant brain development and well-being postpartum. We examined infant brain development with an MRI (Magnetic Resonance Imaging). This data will provide important information on mood and stress during pregnancy, and how it relates to infant brain development.
Funded by NIMH and Medical Research Foundation of Oregon.
Investigation of Pregnancy, Environment, and Neurodevelopment
The iOPEN Study was interested in working with pregnant people and infants to learn more about pregnancy, parenting, and infant brain development.
Maternal Well-Being Study
Postpartum depression is a major public health concern, with consequences that can be enduring for women and their children. However, few evidence-based preventative interventions are available for women at high risk for developing postpartum depression.
The focus of the Maternal Well-Being Study was to connect women with training in skills that promote well-being, reduce mood symptoms, and improve emotional responding during pregnancy and postpartum. We used neuroimaging (Magnetic Resonance Imaging or MRI) to examine how a mindfulness-based intervention, MBCT (Mindfulness-Based Cognitive Therapy), for pregnant women who may be at heightened risk for developing depressive symptoms may work to reduce mood symptoms postpartum.
Funded by the NIH (1R21AT010292-01) and Medical Research Foundation of Oregon.